Your browser doesn't support javascript.
loading
Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic E. coli.
Pollock, Georgina L; Grishin, Andrey M; Giogha, Cristina; Gan, Jiyao; Oates, Clare V; McMillan, Paul J; Gaeta, Isabella; Tyska, Matthew J; Pearson, Jaclyn S; Scott, Nichollas E; Cygler, Miroslaw; Hartland, Elizabeth L.
Afiliación
  • Pollock GL; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
  • Grishin AM; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia.
  • Giogha C; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Gan J; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Oates CV; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
  • McMillan PJ; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia.
  • Gaeta I; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
  • Tyska MJ; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia.
  • Pearson JS; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
  • Scott NE; Biological Optical Microscopy Platform and Department of Biochemistry & Pharmacology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3010, Australia.
  • Cygler M; Department of Cell and Developmental Biology, University Medical Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Hartland EL; Department of Cell and Developmental Biology, University Medical Center, Vanderbilt University School of Medicine, Nashville, TN.
Proc Natl Acad Sci U S A ; 119(34): e2204332119, 2022 08 23.
Article en En | MEDLINE | ID: mdl-35976880
ABSTRACT
Attaching and effacing (AE) lesion formation on enterocytes by enteropathogenic Escherichia coli (EPEC) requires the EPEC type III secretion system (T3SS). Two T3SS effectors injected into the host cell during infection are the atypical kinases, NleH1 and NleH2. However, the host targets of NleH1 and NleH2 kinase activity during infection have not been reported. Here phosphoproteomics identified Ser775 in the microvillus protein Eps8 as a bona fide target of NleH1 and NleH2 phosphorylation. Both kinases interacted with Eps8 through previously unrecognized, noncanonical "proline-rich" motifs, PxxDY, that bound the Src Homology 3 (SH3) domain of Eps8. Structural analysis of the Eps8 SH3 domain bound to a peptide containing one of the proline-rich motifs from NleH showed that the N-terminal part of the peptide adopts a type II polyproline helix, and its C-terminal "DY" segment makes multiple contacts with the SH3 domain. Ser775 phosphorylation by NleH1 or NleH2 hindered Eps8 bundling activity and drove dispersal of Eps8 from the AE lesion during EPEC infection. This finding suggested that NleH1 and NleH2 altered the cellular localization of Eps8 and the cytoskeletal composition of AE lesions during EPEC infection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfotransferasas / Proteínas de Escherichia coli / Proteínas Adaptadoras Transductoras de Señales / Infecciones por Escherichia coli / Escherichia coli Enteropatógena Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfotransferasas / Proteínas de Escherichia coli / Proteínas Adaptadoras Transductoras de Señales / Infecciones por Escherichia coli / Escherichia coli Enteropatógena Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article País de afiliación: Australia